Bladder cancer trials in South Korea

In South Korea 35 Also abroad 625

35 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Where
Cheongju-si, Goyang-si, Seoul
Age
18 years and over
People
1,006 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00
Phase 2Taking people
The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy
Where
Goyang-si
Age
20 years and over
People
82
Run by
National Cancer Center, Korea
See details and how to joinNCT06388720
No phaseTaking people
Early vs Delayed Intravesical Blad-Care During BCG Therapy
Where
Seoul
Age
19 years and over
People
56
Run by
BLAD-HYA Group
See details and how to joinNCT07495072
No phaseTaking people
Korean Prospective Upper Tract Urothelial Carcinoma Cohort
Where
Seoul
Age
19 years and over
People
300
Run by
Samsung Medical Center
See details and how to joinNCT07452432
Phase 2Taking people
Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC
Where
Seoul
Age
20 years and over
People
48
Run by
Samsung Medical Center
See details and how to joinNCT07225374
No phaseNot yet taking people in South Korea
Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer
Where
Goyang-si
Age
19 years and over
People
54
Run by
National Cancer Center, Korea
See details and how to joinNCT07125924
No phaseTaking people
Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM)
Where
Seoul
Age
20 years and over
People
53
Run by
Samsung Medical Center
See details and how to joinNCT05453682
No phaseTaking people
Prediction of Therapeutic Response to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer Patients Using Spatial Transcriptomics
Where
Seoul
Age
18 years to 80 years
People
250
Run by
Yonsei University
See details and how to joinNCT06373055
No phaseTaking people
Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome
Where
Seoul
Age
20 years and over
People
3,000
Run by
Yonsei University
See details and how to joinNCT04625556
No phaseTaking people
Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA
Where
Seoul
Age
20 years and over
People
3,000
Run by
Yonsei University
See details and how to joinNCT04197414